Can the European Medicines Agency (EMA) be truly independent, if it also is in close contact with the pharmaceutical industry? Last week , experts discussed this (and other related topics) at our event in the European Parliament, which Wemos co-organized with the European Parliament group of SP (GUE/NGL).
There will be no European ban on the endocrine-disrupting chemical Bisphenol A (BPA). The European Parliament has voted that BPA will remain in food contact materials. Wemos regrets that European citizens will therefore remain exposed to this harmful substance.
Today Wemos participates in the Global Health Symposium at the University of Groningen. The symposium focuses on the topic ‘Crossing borders and boundaries in medicine: exploring migration, care and culture.
How does the pharmaceutical industry influence the European Medicines Agency? Can the organization independently carry out its work? Experts will discuss this in the European Parliament at an event on January 9th organized by Wemos and the European Parliament group of SP (GUE/NGL).
The lack of health professionals worldwide is estimated around 18 million in 2030, especially in low- and middle-income countries. But still many African doctors in training doubt whether they will and can join the public health sector after graduating. Not surprising, because African doctors in training are strongly confronted with the existing problems in their health system.